Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
ConcertAI Names Catherine Richards as its First Chief Data Officer and RWD Products Head
ConcertAI, LLC (ConcertAI), a market leader for real-world data (RWD) and enterprise AI technology solutions […]
Alder Hey Launches First Startup Collaboration Programme
Today, Alder Hey Children’s NHS Foundation Trust is launching our first start-up accelerator programme: Alder […]
GeneQuantum Announces a Key Leadership Appointment
GeneQuantum Healthcare, an industry leading biopharmacetucial company dedicated to next generation bioconjugate drugs through innovative […]
Technology Effective Against Antibiotic-Resistant Pathogen
Vomaris Innovations, Inc. announced today the publication of results demonstrating that the company’s bioelectric V.Dox™ Technology […]
Musculoskeletal (MSK) Funding Opens
Funding has been created to support Integrated Care Systems (ICSs) who have an active interest […]
Royal Wolverhampton NHS Trust (RWT) and Babylon bring digital-first, value-based healthcare to over 55,000 people across Wolverhampton
Royal Wolverhampton NHS Trust (RWT) and Babylon today announced they have extended their partnership to bring […]
BioAgilytix to Purchase Australia-Based 360biolabs®
BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical […]
New Drug Combo for Advanced Breast Cancer Approved for NHS in England
The National Institute of Health and Care Excellence (NICE) has approved the use of a […]
Olive Adopts AWS as its Preferred Cloud Provider to Create the Internet of Healthcare
Olive, the automation company creating the Internet of Healthcare, announced a strategic relationship today with […]
Butterfly Network and Caption Health Announce Exclusive Strategic Partnership to Enable Earlier Disease Detection and Management with AI-Based Guidance and Diagnostics
Butterfly Network, Inc. (NYSE: BFLY), manufacturer of Butterfly iQ+, the world’s first handheld whole-body ultrasound […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more